ORCL

Oracle Corporation

65
Fundamentals60/ 100
Valuation78/ 100
Upside potential73/ 100
Risk potential19/ 100

ORCL has lower modeled downside risk, despite its lower overall score.

ZETA

Zeta Global Holdings Corp.

73
Fundamentals79/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential36/ 100

ZETA has the edge over ORCL overall, supported by stronger fundamentals.

ORCL Fundamentals

MetricStatus
Healthy
Strong
Weak
Strong

ORCL's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

ZETA Fundamentals

MetricStatus
Strong
Healthy
Strong
Healthy

ZETA's revenue, profitability, cash flow and balance sheet are all currently healthy.

ORCL PE Valuation

CHEAPFAIREXPENSIVE19x37x56x74x
CHEAPFAIREXPENSIVE19x37x56x74x
LevelPEPriceVs current
Forward15x$127—
Cheap19x$119-6.8%
Current20x$127—
Fair30x$189+49%
Expensive39x$247+94%

Historical ranges are pointers, not guarantees.

ORCL's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.

ZETA PE Valuation

LevelPEPriceVs current
Forward29x$37.27—
Current248x$37.27—
CheapN/AN/AN/A
FairN/AN/AN/A
ExpensiveN/AN/AN/A

Historical ranges are pointers, not guarantees.

ZETA has the edge over ORCL in the historical PE scenario, which offers more potential upside but is not a forecast.

ORCL Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly weakening
Moderate
High

Analysts expect strong earnings and revenue growth for ORCL, but weaker profitability.

ZETA Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
Low

ZETA has the edge over ORCL on the outlook, with more favorable profitability expectations.

ORCL Risk to reward

ScenarioChangePrice
Upside+52%$192.98
Downside-19%$102.46

Calculated from the latest close: $127.11 on Nov 12.

ORCL has a better modeled risk to reward balance than ZETA, with more potential upside relative to its potential downside.

ZETA Risk to reward

ScenarioChangePrice
Upside+60%$59.54
Downside-36%$23.87

Calculated from the latest close: $37.27 on Nov 12.

ZETA trails ORCL on modeled risk to reward, with less potential upside relative to its potential downside.

ORCL Earnings Per Share

Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
QuarterTTM EPSYoY
Forward$8.53+34%
Q3 2026$6.38+48%
Q2 2026$5.83+34%
Q1 2026$5.57+31%
Q4 2025$5.32+30%
Q3 2025$4.32+11%
Q2 2025$4.34+17%
Q1 2025$4.26+12%
Q4 2024$4.09+13%

ORCL's earnings per share have climbed steadily: $6.38 over the past year, up 48% from the year before, and higher year over year for 15 quarters in a row.

ZETA Earnings Per Share

Q4 2023: $-1.20Q1 2024: $-1.05Q2 2024: $-0.87Q3 2024: $-0.69Q4 2024: $-0.38Q1 2025: $-0.25Q2 2025: $-0.15Q3 2025: $-0.08Q4 2025: $-0.14Q1 2026: $-0.10Q2 2026: $-0.01Q3 2026: $0.15Forward: $1.27
Q4 2023: $-1.20Q1 2024: $-1.05Q2 2024: $-0.87Q3 2024: $-0.69Q4 2024: $-0.38Q1 2025: $-0.25Q2 2025: $-0.15Q3 2025: $-0.08Q4 2025: $-0.14Q1 2026: $-0.10Q2 2026: $-0.01Q3 2026: $0.15Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27+748%
Q3 2026$0.15+$0.23
Q2 2026-$0.01+$0.14
Q1 2026-$0.10+$0.15
Q4 2025-$0.14+$0.24
Q3 2025-$0.08+$0.61
Q2 2025-$0.15+$0.72
Q1 2025-$0.25+$0.80
Q4 2024-$0.38+$0.82

ZETA has returned to profit: it earned $0.15 per share over the past year, after losing money the year before.

ORCL Quarterly Revenue

Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
QuarterRevenueYoY
Q3 2026$19.3B+30%
Q2 2026$19.2B+21%
Q1 2026$17.2B+22%
Q4 2025$16.1B+14%
Q3 2025$14.9B+12%
Q2 2025$15.9B+11%
Q1 2025$14.1B+6.4%
Q4 2024$14.1B+8.6%

ORCL's revenue has grown year over year for 13 quarters in a row: $19.3B last quarter, up 30% from the same quarter a year ago.

ZETA Quarterly Revenue

Q4 2023: $210MQ1 2024: $195MQ2 2024: $228MQ3 2024: $268MQ4 2024: $315MQ1 2025: $264MQ2 2025: $308MQ3 2025: $337MQ4 2025: $395MQ1 2026: $396MQ2 2026: $443MQ3 2026: $493M
Q4 2023: $210MQ1 2024: $195MQ2 2024: $228MQ3 2024: $268MQ4 2024: $315MQ1 2025: $264MQ2 2025: $308MQ3 2025: $337MQ4 2025: $395MQ1 2026: $396MQ2 2026: $443MQ3 2026: $493M
QuarterRevenueYoY
Q3 2026$492.7M+46%
Q2 2026$442.8M+44%
Q1 2026$396.3M+50%
Q4 2025$394.6M+25%
Q3 2025$337.2M+26%
Q2 2025$308.4M+35%
Q1 2025$264.4M+36%
Q4 2024$314.7M+50%

ZETA has the edge over ORCL on sales, with stronger typical year-over-year growth.

ORCL Free Cash Flow

Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
QuarterFree cash flowYoY
Q3 2026-$5.4B-$5B
Q2 2026-$1.9B+$1.1B
Q1 2026-$11.5B-16275%
Q4 2025-$10B-$7.3B
Q3 2025-$362M-107%
Q2 2025-$2.9B-189%
Q1 2025$71M-98%
Q4 2024-$2.7B-$1.7B

ORCL has burned cash in seven of the last eight quarters: −$28.7B over the past year, against −$5.9B the year before.

ZETA Free Cash Flow

Q4 2023: $21MQ1 2024: $19MQ2 2024: $24MQ3 2024: $30MQ4 2024: $35MQ1 2025: $32MQ2 2025: $40MQ3 2025: $52MQ4 2025: $61MQ1 2026: $47MQ2 2026: $64MQ3 2026: $88M
Q4 2023: $21MQ1 2024: $19MQ2 2024: $24MQ3 2024: $30MQ4 2024: $35MQ1 2025: $32MQ2 2025: $40MQ3 2025: $52MQ4 2025: $61MQ1 2026: $47MQ2 2026: $64MQ3 2026: $88M
QuarterFree cash flowYoY
Q3 2026$88.3M+68%
Q2 2026$64.4M+62%
Q1 2026$46.7M+46%
Q4 2025$60.9M+72%
Q3 2025$52.4M+78%
Q2 2025$39.7M+63%
Q1 2025$32.1M+70%
Q4 2024$35.4M+66%

ZETA has the edge over ORCL on cash generation, producing positive trailing cash flow while its opponent burns cash.

ORCL Total Shares

Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
PeriodChange %Net change
Quarterly+3%+86M shares
1 year+3.1%+91M shares
3 years+6.3%+177M shares
5 years+4.9%+139M shares
Available history-9.9%-331M shares

ORCL has the edge over ZETA on shareholder dilution, with a more favorable share count trend.

ZETA Total Shares

Q4 2023: 157MQ1 2024: 171MQ2 2024: 178MQ3 2024: 188MQ4 2024: 186MQ1 2025: 213MQ2 2025: 217MQ3 2025: 222MQ4 2025: 221MQ1 2026: 239MQ2 2026: 257MQ3 2026: 265M
Q4 2023: 157MQ1 2024: 171MQ2 2024: 178MQ3 2024: 188MQ4 2024: 186MQ1 2025: 213MQ2 2025: 217MQ3 2025: 222MQ4 2025: 221MQ1 2026: 239MQ2 2026: 257MQ3 2026: 265M
PeriodChange %Net change
Quarterly+3.1%+8M shares
1 year+19%+42.2M shares
3 years+67%+107M shares
5 years+417%+213M shares
Available history+712%+232M shares

ZETA has 265M diluted shares, up 19% from a year ago.

ORCL Net Leverage

Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
QuarterNet LeverageStatus
Q3 2026-0.9xNet Cash
Q2 20263.5xElevated
Q1 20260.5xVery low
Q4 20250.3xVery low
Q3 2025-0.1xNet Cash
Q2 20253.7xElevated
Q1 20250.2xVery low
Q4 20240.2xVery low

ORCL has the edge over ZETA on leverage, with a lower net debt burden relative to earnings.

ZETA Net Leverage

Q1 2025: -14.1xQ2 2025: -4.5xQ3 2025: -3.0xQ4 2025: -1.6xQ1 2026: -1.1xQ2 2026: -1.0xQ3 2026: -0.7x
Q1 2025: -14.1xQ2 2025: -4.5xQ3 2025: -3.0xQ4 2025: -1.6xQ1 2026: -1.1xQ2 2026: -1.0xQ3 2026: -0.7x
QuarterNet LeverageStatus
Q3 2026-0.7xNet Cash
Q2 2026-1.0xNet Cash
Q1 2026-1.1xNet Cash
Q4 2025-1.6xNet Cash
Q3 2025-3.0xNet Cash
Q2 2025-4.5xNet Cash
Q1 2025-14.1xNet Cash

ZETA has more cash than debt.

ORCL Weekly Momentum

MetricValueStatus
RSI41.9Neutral
Stochastic23.0Neutral

ORCL's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).

ZETA Weekly Momentum

MetricValueStatus
RSI70.3Overbought
Stochastic75.8Neutral

ZETA's weekly RSI is 70 (overbought) and its Stochastic is 76 (neutral).

ORCL PE vs Technology Sector

MetricORCLSector medianRelative
PE20x28x28% below
PE %28357 pts below

ORCL is trading at 20x earnings, a 28% discount to the Technology sector's median of 28x.

ZETA PE vs Technology Sector

ORCL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$131.13.1% below
20 week MA$137.67.7% below
50 week MA$160.321% below
100 week MA$181.430% below
200 week MA$151.916% below

ORCL is in a downtrend: it's below all five of its weekly moving averages, and 16% below its 200-week average.

ZETA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$32.615% above
20 week MA$28.630% above
50 week MA$22.665% above
100 week MA$19.789% above
200 week MA$16.7123% above

ZETA has the edge over ORCL on trend strength, trading above more of its moving averages.

ORCL Yearly ROI

YearStart priceEnd priceROI
2020$53.5$65.0+22%
2021$65.0$89.7+38%
2022$89.7$80.9-9.9%
2023$80.9$105.4+30%
2024$105.4$169.0+60%
2025$169.0$198.0+17%
2026 YTD$198.0$127.1-36%

ORCL is down 36% so far in 2026, after finishing higher in five of the previous six years.

ZETA Yearly ROI

YearStart priceEnd priceROI
2021$8.27$8.40+1.6%
2022$8.40$8.21-2.3%
2023$8.21$8.82+7.4%
2024$8.82$17.7+100%
2025$17.7$20.7+17%
2026 YTD$20.7$37.3+80%

ZETA has the edge over ORCL on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key